July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR).

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that the first patient has been enrolled in its MOJAVE study.

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin


Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than Intravascular ultrasound (IVUS), making it ideal for clinical trials of cardi


July 7, 2023 — Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, 

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver.

July 7, 2023 — Launched by Mitrelli Group, Menomadin Foundation, Save a Child’s Heart, Côte d’Ivoire Health Ministry and Abidjan Institute of Cardiology; Côte d’Ivoire Minister of Health: “Health-independence is a national strategic priority, and this project is a major step on the road to that vital goal.” ; Taking part in the project: Mitrelli’ s health subsidiary

Subscribe Now